BCL2 and mycosis fungoides: The Western blot analyses of MF skin lesions treated with Pc 4-PDT confirmed that this treatment is capable of reducing intracellular levels of Bcl-2 in malignant T-lymphocytes in vivo, consistent with our previous in vitro data [12].